Start with a free account for 3 free CME credits. Already a subscriber? Sign in.
Free Episode

The Primary Care RAP Hot Sheet: December 2016

Andrew Buelt, DO and Heidi James, MD
00:00
05:55

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

Andrew and Heidi talk about medical marijuana legislation, new statin guidelines, and the diabetes drug that has everyone talking.

Ian L., Dr -

With the new Diabetis drug class SGLT2 adverse effects of Euglycemic diabetic ketoacidosis is seen if not Diabetis type 2 eg Maturity Onset Diabetis of the young or latent autoimmune Diabetis of insulin or slow onset Diabetis one .
C-Peptide testing to confirm endogenous insulin is a wise precaution .
Beware Dehydration on hot days .
Beware use in the elderly because of postural hypotension not worth the risk .

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.

To download files, you need to subscribe.

Sign up today for full access to all episodes.
The Primary Care RAP Hot Sheet: December 2016 Full episode audio for MD edition 5:57 min - 3 MB - M4A